Debut Plus

₹22.97

■ +0 +0.00%

As of 19 Oct 2026 · delayed

BSE Listed

GSM · GSM 4
What does GSM · GSM 4 mean?
BSE · Graded Surveillance Measure (GSM 4)GSM targets fundamentally weak companies whose price doesn't square with their financials (tiny net worth or negative/extreme P/E). Practical meaning: the exchange doubts the price is backed by the business. Stage 0 is a watchlist; each higher stage makes the stock progressively harder to trade — tighter bands, full upfront margin, weekly-only trading, and at Stage IV no upward price movement at all. Exiting requires a quarterly review finding the criteria no longer met.Criteria: Shortlisted on objective financial parameters — net worth, net fixed assets, price-to-earnings multiple and market capitalisation. Stage 0 = base surveillance watchlist (identified under GSM, no graded price restriction yet); Stages I–VI add escalating curbs (price band, 100% margin, periodic call auction, settlement on a gross/trade-for-trade basis, no upward price movement).Exchange notice · 2026-06-05

Hemo Organic Limited (524590)

Volume: 5,342Avg Vol 1W: 19,981Avg Vol 1M: 21,37152W Range:₹8.29₹24.42
Market Cap₹8 Cr
Current Price₹22.97
Previous Close₹22.97
High / Low (52w)₹24.42 / ₹8.29
Volume5,342
Avg Vol (1W)19,981
Avg Vol (1M)21,371
Stock P/E—
Book Value₹-0.43
Dividend Yield0%
ROE-22.46%
ROA-15.34%
Revenue (TTM)—
Revenue Growth—
Profit Margin-30.93%
Total Debt—
Shares Outstanding0 Cr
Face Value—
EPS (TTM)₹0
P/B0
Debt / Equity0
50 DMA₹18.13
200 DMA₹14.28
Day change+0.00%
SurveillanceGSM · GSM 4
Price Chart
₹22.97▲ 175.75% · 1Y
₹24₹81.5L
2025-10-27
2026-10-19

20-day avg volume: 22K shares

Pros
  • Company is almost debt-free.
Cons
  • Revenue fell 63% YoY.
  • Company is loss-making at the latest annual result.
  • Negative book value per share.
Quarterly Results
MetricDec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026Sept 2026
Revenue₹0 Cr₹2 Cr₹0 Cr₹0 Cr₹0 Cr₹1 Cr₹0 Cr₹1 Cr
EBITDA₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Net Profit₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹-1 Cr₹0 Cr₹0 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹2 Cr₹1 Cr
EBITDA₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Net Profit₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹-1 Cr
EPS-0.35-0.06-0.14-0.18-0.16-0.760.47-2.24
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹1 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹1 Cr₹5 Cr₹4 Cr
Total Liabilities₹1 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹1 Cr₹5 Cr₹4 Cr
Equity₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Total Debt————————
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹0 Cr₹0 Cr₹0 Cr₹-1 Cr₹0 Cr₹-1 Cr
Investing₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹-1 Cr
Financing₹0 Cr₹0 Cr₹0 Cr₹1 Cr₹0 Cr₹2 Cr
Free Cash Flow₹0 Cr₹0 Cr₹0 Cr₹-1 Cr₹0 Cr₹-1 Cr
Shareholding
Promoter 2.5% Institutions 0% Public 97.5%
Efficiency & Working Capital
ROCE-9.1%
Interest Coverage0
Dividend Payout—
Debtor Days938 d
Inventory Days200 d
Payable Days613 d
Cash Conversion Cycle525 d
Working Capital Days1138 d
Shareholding Details

As of 2026-09-30

Promoter2.5%
FII0%
DII0%
Institutions0%
Public97.5%
Promoter Pledge0%
No. of Shareholders4,728
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodDec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026Sept 2026
Promoters16.8%16.8%16.8%16.8%16.8%16.8%16.8%16.8%16.8%16.8%16.8%2.5%
FIIs0%0%0%0%0%0%0%0%0%0%0%0%
DIIs0%0%0%0%0%0%0%0%0%0%0%0%
Public83.2%83.2%83.2%83.2%83.2%83.2%83.2%83.2%83.2%83.2%83.2%97.5%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders5,3805,1784,9024,7745,0485,2185,2125,2135,0554,9884,8214,728
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603————
Major Shareholders (>1%)
NameCategoryStakeShares
Vacro Enterprises Private LimitedPublic Shareholding24.8%17,00,000
Qmin Realities Private LimitedPublic Shareholding24.8%17,00,000
Dineshbhai Shanabhai PatelShareholding of Promoter and Promoter Group2.4%1,64,968
Ketanaben Dharmendrabhai JasaniPublic Shareholding2.3%1,55,986
Heemaben Vatsal MakadiaPublic Shareholding2.3%1,55,986
Ayush Dharmendrabhai JasaniPublic Shareholding1.8%1,26,073
Mitalben Rupeshbhai DesaiPublic Shareholding1.8%1,21,002
Rupesh Ramanlal DesaiPublic Shareholding1.8%1,20,795
Jasani Dharmendra Bhai BecharbhaiPublic Shareholding1.6%1,11,341
Ayush Dharmendrabhai JasaniPublic Shareholding1.5%1,00,000
Mansukhlal Chhotalal ShahPublic Shareholding1.3%87,044
Ruchira GoyalPublic Shareholding1%69,000
Sonalben Dineshbhai PatelShareholding of Promoter and Promoter Group0.1%7,000
Board of Directors
NameDesignationYear
Vishwambar Kameshwar SinghManaging Director2026
Murlidhar JoshiNon Independent Non Executive Director / CFO2026
Hiral Vinodbhai PatelIndependent Non Exe. Director2026
Rina KumariIndependent Non Exe. Director2026
Ayush Dharmendrabhai JasaniChairperson & Additional Direc2026
Pratibha SharmaCompany Secretary / Compliance Officer2026
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹101333
Corporate Actions
TypeDateValueRemark
forthcoming2026-07-15Board Meetings—
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2026000101
2026000101
2026000000
Insider / Designated-Person Trades

5 recent disclosure(s)

Jasani Family Private TrustAcquisition · 1,00,000
Heemaben MakadiaAcquisition · 1,55,986
Ketnaben JasaniAcquisition · 1,55,986
Dineshbhai Shanabhai PatelDisposal · 60,000
Dineshbhai Shanabhai PatelDisposal · 3,11,972
Substantial Acquisitions (SAST)

4 disclosure(s)

Off Market24/09/2026 · 4,11,972
Off Market24/09/2026 · 60,000
Off Market23/09/2026 · 40,000
Off Market23/09/2026 · 3,11,972
Company Information
Incorporated1992
ChairmanAyush Dharmendrabhai Jasani
AuditorMAAK & Associates/VSSB & Associates
Investor Email[email protected]
🌐 www.hemoorganic.com ↗

📍 Shop 1 to 3 First Flr, Piyu Apartment Nikol Gam Road, Ahmedabad, Gujarat, 382350

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search